Trial Profile
A phase II trial of Doxil [doxorubicin liposomal] and multiday vinorelbine in patients with metastatic breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Jul 2006 New trial record.